Gene therapy for cancer: bacteria-mediated anti-angiogenesis therapy. (Q37828065)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21228886%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

review article

1 reference

title

Gene therapy for cancer: bacteria-mediated anti-angiogenesis therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21228886%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

0 references

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21228886%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

R Gardlik

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21228886%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

M Behuliak

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21228886%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

R Palffy

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21228886%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

C J Li

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21228886%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

13 January 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21228886%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21228886%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21228886%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21228886%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

425-431

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21228886%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/gt.2010.176

19 January 2020

exact match

0 references

cites work

Bifidobacterium longum as a delivery system for cancer gene therapy: selective localization and growth in hypoxic tumors

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

Facultative or obligate anaerobic bacteria have the potential for multimodality therapy of solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

Containment of tumor-colonizing bacteria by host neutrophils.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

Bacteria as tumour-targeting vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

Bacterial targeted tumour therapy-dawn of a new era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

Biological gene delivery vehicles: beyond viral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

Cancer metastasis directly eradicated by targeted therapy with a modified Salmonella typhimurium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

Systemic targeting of primary bone tumor and lung metastasis of high-grade osteosarcoma in nude mice with a tumor-selective strain of Salmonella typhimurium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

Tumor-targeted Salmonella expressing cytosine deaminase as an anticancer agent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

Attenuated Salmonella targets prodrug activating enzyme carboxypeptidase G2 to mouse melanoma and human breast and colon carcinomas for effective suicide gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

Tumor-targeting prodrug-activating bacteria for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

Oral delivery of tumor-targeting Salmonella exhibits promising therapeutic efficacy and low toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

The first clinical use of a live-attenuated Listeria monocytogenes vaccine: a Phase I safety study of Lm-LLO-E7 in patients with advanced carcinoma of the cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

Short hairpin RNA-expressing bacteria elicit RNA interference in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

Recent advances in bacillus Calmette-Guerin immunotherapy in bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

Bacteriolytic therapy can generate a potent immune response against experimental tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

A dityrosyl-diiron radical cofactor center is essential for human ribonucleotide reductases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

Enhanced therapeutic effect by combination of tumor-targeting Salmonella and endostatin in murine melanoma model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

Endostatin gene therapy delivered by Salmonella choleraesuis in murine tumor models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

Oral cytokine gene therapy against murine tumor using attenuated Salmonella typhimurium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

Live attenuated Salmonella as a vector for oral cytokine gene therapy in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

Antitumor therapeutic effects of Salmonella typhimurium containing Flt3 Ligand expression plasmids in melanoma-bearing mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

Systemic administration of attenuated Salmonella choleraesuis carrying thrombospondin-1 gene leads to tumor-specific transgene expression, delayed tumor growth and prolonged survival in the murine melanoma model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

Engineered E. coli delivers therapeutic genes to the colonic mucosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

Bactofection of lung epithelial cells in vitro and in vivo using a genetically modified Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

An autologous oral DNA vaccine protects against murine melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

Vascular endothelial growth factor receptor 2-based DNA immunization delays development of herpetic stromal keratitis by antiangiogenic effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

Vaccination against VEGFR2 attenuates initiation and progression of atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

DNA vaccination against VEGF receptor 2 reduces atherosclerosis in LDL receptor-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

The enhanced anti-angiogenic and antitumor effects of combining flk1-based DNA vaccine and IP-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

Transcription factor Fos-related antigen 1 is an effective target for a breast cancer vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

Endoglin (CD105) is a target for an oral DNA vaccine against breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

Anti-tumor immunotherapy via antigen delivery from a live attenuated genetically engineered Pseudomonas aeruginosa type III secretion system-based vector.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

Oral DNA vaccines target the tumor vasculature and microenvironment and suppress tumor growth and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

Bacteria in gene therapy: bactofection versus alternative gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

Genetically engineered Bifidobacterium longum for tumor-targeting enzyme-prodrug therapy of autochthonous mammary tumors in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

Clostridial spores as live 'Trojan horse' vectors for cancer gene therapy: comparison with viral delivery systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

A genetically enhanced anaerobic bacterium for oncopathic therapy of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

Bifidobacterium adolescentis as a delivery system of endostatin for cancer gene therapy: selective inhibitor of angiogenesis and hypoxic tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

A new expression plasmid in Bifidobacterium longum as a delivery system of endostatin for cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

Bifidobacterium longum as an oral delivery system of endostatin for gene therapy on solid liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

Bifidobacterium longum as a delivery system of TRAIL and endostatin cooperates with chemotherapeutic drugs to inhibit hypoxic tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

Remote control of tumour-targeted Salmonella enterica serovar Typhimurium by the use of L-arabinose as inducer of bacterial gene expression in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

Tumor-specific colonization, tissue distribution, and gene induction by probiotic Escherichia coli Nissle 1917 in live mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

Development of a flexible and potent hypoxia-inducible promoter for tumor-targeted gene expression in attenuated Salmonella.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

Bacterial delivery of a novel cytolysin to hypoxic areas of solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

Salmonella promoters preferentially activated inside tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

Prodrug converting enzyme gene delivery by L. monocytogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

Attenuated Salmonella engineered to produce human cytokine LIGHT inhibit tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

IL-18-producing Salmonella inhibit tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

Salmonella typhimurium engineered to produce CCL21 inhibit tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

Inhibition of tumor growth using salmonella expressing Fas ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

Potent anti-tumor activity of systemically-administered IL2-expressing Salmonella correlates with decreased angiogenesis and enhanced tumor apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

Pilot trial of genetically modified, attenuated Salmonella expressing the E. coli cytosine deaminase gene in refractory cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

Transkingdom RNA interference (tkRNAi) as a new delivery tool for therapeutic RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

High-throughput screening of effective siRNAs from RNAi libraries delivered via bacterial invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

Using attenuated Salmonella typhi as tumor targeting vector for MDR1 siRNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

Intratumoral delivery and suppression of prostate tumor growth by attenuated Salmonella enterica serovar typhimurium carrying plasmid-based small interfering RNAs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

Oral administration of attenuated S. typhimurium carrying shRNA-expressing vectors as a cancer therapeutic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

Angiogenic potential of prostate carcinoma cells overexpressing bcl-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

Efficient siRNA delivery using water soluble lipopolymer for anti-angiogenic gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

Adenovirus-mediated small interfering RNA against matrix metalloproteinase-2 suppresses tumor growth and lung metastasis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

Short interfering RNA (siRNA), a novel therapeutic tool acting on angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth

21 January 2018

2 references

https://api.crossref.org/works/10.1038%2FGT.2010.176

21 January 2018

https://api.crossref.org/works/10.1038%2FGT.2010.176

7 January 2021

Combination therapy with bacteria and angiogenesis inhibitors: strangling cancer without mercy

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

7 January 2021

Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

7 January 2021

Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

7 January 2021

VEGF-targeted RNA interference suppresses angiogenesis and tumor growth of retinoblastoma

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

7 January 2021

Inhibition of hypoxia-inducible factor-1alpha and endothelial progenitor cell differentiation by adenoviral transfer of small interfering RNA in vitro

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.176

7 January 2021